Bay Harbor Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150K Buy
591
+185
+46% +$43.1K 0.03% 77
2026
Q1
$99.3K Buy
406
+257
+172% +$59.9K 0.03% 92
2025
Q4
$30.8K Buy
149
+49
+49% +$9.69K 0.01% 123
2025
Q3
$18.5K Buy
100
+29
+41% +$4.97K 0.01% 130
2025
Q2
$10.8K Buy
71
+24
+51% +$3.69K ﹤0.01% 142
2025
Q1
$7.79K Sell
47
-176
-79% -$27.5K ﹤0.01% 127
2024
Q4
$32.3K Buy
+223
New +$34.6K 0.01% 112
2023
Q4
Sell
-308
Closed -$48K 177
2023
Q3
$48K Sell
308
-92
-23% -$15.2K 0.02% 96
2023
Q2
$66.2K Buy
+400
New +$64.6K 0.03% 81
2021
Q1
Sell
-194
Closed -$31K 329
2020
Q4
$31K Hold
194
0.01% 187
2020
Q3
$29K Hold
194
0.01% 189
2020
Q2
$27K Buy
194
+3
+2% +$437 0.01% 189
2020
Q1
$25K Hold
191
0.02% 176
2019
Q4
$28K Sell
191
-50
-21% -$6.78K 0.02% 183
2019
Q3
$32K Hold
241
0.02% 184
2019
Q2
$34K Sell
241
-35
-13% -$4.84K 0.02% 190
2019
Q1
$39K Sell
276
-351
-56% -$47K 0.03% 182
2018
Q4
$81K Buy
+627
New +$87.5K 0.06% 127

Other funds holding JNJ

Bay Harbor Wealth Management's JNJ Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Johnson & Johnson (JNJ) stake by 46% in Q2 2026, buying an estimated $43.1K and bringing the position to 591 shares worth $150K. The position accounts for 0.03% of the portfolio, ranked #77.

Bay Harbor Wealth Management first reported a position in JNJ in Q4 2018 and has held it in 18 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bay Harbor Wealth Management held 591 shares of Johnson & Johnson worth $150K as of Q2 2026.
  • Bay Harbor Wealth Management bought 185 Johnson & Johnson shares in Q2 2026, an estimated $43.1K.
  • Johnson & Johnson made up 0.03% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #77 holding.
  • Bay Harbor Wealth Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 18 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.